News | June 22, 2012

University of Miami’s Stem Cell Institute Awarded $10 Million

Grant to support stem cell institute's mission to translate stem cell discoveries into pipeline of therapies for heart disease


June 22, 2012 — The University of Miami Miller School of Medicine’s Interdisciplinary Stem Cell Institute (ISCI) announced that it received a $10 million grant from The Starr Foundation, one of the largest private foundations in the United States. The grant will support ISCI in broadening its pre-clinical and clinical research on stem cells, and help accelerate its pipeline of translational research and programs for a wide range of debilitating conditions including cardiac disease, cancer, wound healing, stroke, glaucoma, and chronic kidney and gastrointestinal diseases.

The Starr Foundation has long been involved in stem cell research and its potential to dramatically change the way physicians treat and cure disease. Similarly, ISCI was founded in 2008 with the goal to discover and advance cell-based therapies for devastating and untreatable diseases and help unlock the power of regenerative medicine. 

ISCI is currently leading 13 clinical trials evaluating the use of stem cells in patients with conditions including congestive heart failure, skin wounds, burns, pulmonary fibrosis and stroke.

For more information: www.med.miami.edu

 


Related Content

News | Stem Cell Therapies

November 19, 2021 — Stem cell therapy helped to reduce the number of heart attacks, strokes and death among people with ...

Home November 19, 2021
Home
News | Stem Cell Therapies

October 28, 2021 – The first patient has been treated in a new trial using stem cell therapy to treat chronic myocardial ...

Home October 28, 2021
Home
Videos | Stem Cell Therapies

Mechanical engineering Professor Nathan Sniadecki, associate chair for research and infrastructure, mechanical ...

Home October 04, 2021
Home
Feature | Stem Cell Therapies | By Simon H. Stertzer, M.D.

Heart failure remains an unheralded global pandemic, costing society billions of dollars each year.[1,2] Projections ...

Home May 11, 2021
Home
Feature | Stem Cell Therapies | By Andy Freeberg

The University of Washington (UW) in Seattle has developed engineered heart tissue that beats. Though minuscule, the ...

Home February 25, 2021
Home
News | Stem Cell Therapies

August 22, 2019 — Renovacor Inc, a preclinical-stage biopharmaceutical company, announced the successful completion of ...

Home August 22, 2019
Home
News | Stem Cell Therapies

May 20, 2019 – Researchers at the Icahn School of Medicine at Mount Sinai have demonstrated that stem cells derived from ...

Home May 20, 2019
Home
News | Stem Cell Therapies

April 19, 2019 — Aziyo Biologics Inc. announced the publication of results from its landmark RECON study in the Journal ...

Home April 19, 2019
Home
News | Stem Cell Therapies

March 4, 2019 — The U.S. Food and Drug Administration (FDA) recently finalized two guidance documents regarding ...

Home March 04, 2019
Home
News | Stem Cell Therapies

February 1, 2019 — A team of Rutgers scientists have taken an important step toward the goal of making diseased hearts ...

Home February 01, 2019
Home
Subscribe Now